Inflammatory Bowel Disease News and Research

Latest Inflammatory Bowel Disease News and Research

Researchers create roadmap to integrin activation

Calling it an important technical advance in the study of the complex receptors and pathways of the body's cellular system, researchers at the University of California, San Diego (UCSD) School of Medicine have reconstructed the signaling pathways that impact activation of a receptor that is critical to the control of bleeding and to the thrombosis that occurs in heart attacks and strokes.

18 Sep 2006

Quality indicators for gastrointestinal endoscopic procedures

Defining measurements and identifying quality standards in the delivery of colonoscopic care is a major priority for the nation's leading gastrointestinal endoscopic healthcare association.

13 Sep 2006

Enrichment of regulatory CD4+CD25+ T cells by inhibition of phospholipase D signaling

A signaling molecule with an affinity for alcohol has yielded a rapid, inexpensive way to make large numbers of immune cells that work like beat cops keeping misguided cells from attacking the body.

8 Aug 2006

Crohn's disease - possible genetic cause found

Patients with Crohn's disease of the colon have one copy less than healthy persons of the beta-defensin 2 gene, a gene coding for an important defense molecule of the body.

17 Jul 2006

Do guidelines for the treatment of osteoporosis in patients with inflammatory bowel disease (IBD) matter?

A new study in the American Journal of Gastroenterology examined the recently set Guidelines regarding the treatment and management of osteoporosis in patients with Inflammatory Bowel Disease (IBD), and found that they are effective.

10 Jul 2006

Importance of T cells in the prevention of autoimmune diseases

Centenary scientist Associate Professor Barbara Fazekas de St. Groth, a leader in inflammatory bowel disease research, has demonstrated for the first time the important role of T cells in the prevention of autoimmune diseases in humans.

9 Jul 2006

Major intestinal surgery may boost the chances of subsequent vitamin A deficiency

Major intestinal surgery, including stomach reduction for obesity, may boost the chances of subsequent vitamin A deficiency, suggests a small study published in the British Journal of Ophthalmology.

14 Jun 2006

Microbes could represent the future of medicine

Not all bacteria are bad. In fact, beneficial microbes could represent the future of medicine, with the potential to treat a variety of diseases in humans and animals from diarrhea and eczema to gum disease and autoimmune disorders.

9 Jun 2006

Humans are a cocktail of bacteria and human cells

Gene experts after studying the DNA of hundreds of different kinds of bacteria in the human gut have reached the conclusion that the human race may not be quite as human as we may think.

4 Jun 2006

Gene variation linked to more severe Crohn's disease

Building on previous evidence supporting the theory that the pathophysiology of Crohn's Disease is altered by genetic variation, recent studies have found that the combination of immune signals given by three variants of a single candidate gene affects the severity of the disease.

1 Jun 2006

Study reveals how production of interferon gamma is controlled in natural killer cells

A new study reveals how the production of a potent immune regulator called interferon gamma (IFNg) is controlled in natural killer (NK) cells, immune cells that typically defend the body against cancer and infections.

31 May 2006

Stem cell 'fusion' occurs in tumors

An Oregon Health & Science University study is adding credence to an increasingly popular theory that fusion is what bonds stem cells with bone marrow cells to regenerate organ tissue.

10 May 2006

IL-25 both promotes and limits inflammatory diseases

The same signal responsible for promoting the type of immune responses that cause asthma and allergy can also limit the type of inflammation associated with debilitating diseases like inflammatory bowel disease, arthritis and multiple sclerosis, according to researchers from the University of Pennsylvania School of Veterinary Medicine.

13 Apr 2006

MIT look at how cells make life-or-death decisions

The biological processes underlying diseases such as rheumatoid arthritis and cancer are fundamentally linked, and should be linked in how they are treated with drugs, a series of MIT studies indicates.

6 Apr 2006

Data from Novogen inflammatory bowel disease drug Phase I clinical trial shows promise

A recently completed Phase 1 clinical trial of an investigational drug to treat inflammatory bowel disease has demonstrated rapid absorption indicating potential for development as an oral therapy.

6 Mar 2006

Drugs formerly contraindicated for inflammatory bowel disease prove beneficial for pain relief

According to two studies published in the American Gastroenterological Association (AGA) journal Clinical Gastroenterology and Hepatology, prescription painkillers are effective in easing the pain of patients with dormant inflammatory bowel disease (IBD) and are not likely to cause symptom flare-ups in IBD patients in remissions

12 Feb 2006

CT enteroclysis should replace conventional enteroclysis in patients with Crohn's disease

The diagnostic value of CT enteroclysis is superior to conventional enteroclysis, previously considered the gold standard, as an imaging method for the evaluation of the small bowel in patients with Crohn's disease, a new study shows.

7 Feb 2006

Eosinophilic esophagitis gene discovery

Researchers at Cincinnati Children's Hospital Medical Center have discovered the first gene associated with eosinophilic esophagitis, one of a number of eosinophil-related diseases in which the body produces abnormally large amounts of white blood cells that can lead to allergy related illnesses.

7 Feb 2006

New biochip predicts evolution of inflammatory bowel disease

The treatment of inflammatory bowel disease, which includes Crohn's disease and ulcerative colitis, has very high costs and can include admissions and surgical interventions. Until now, there was no precise tools to predict the evolution and prognosis of these diseases.

26 Jan 2006

UCLA examines disease-versus-disease interactions

The knowledge that one disease may prevent the onset of another is not new. For example, the discovery that cowpox vaccines can prevent smallpox dates back to 1798.

5 Jan 2006

Inflammatory Bowel Disease News and Research

Latest Inflammatory Bowel Disease News and Research

Researchers create roadmap to integrin activation

Quality indicators for gastrointestinal endoscopic procedures

Enrichment of regulatory CD4+CD25+ T cells by inhibition of phospholipase D signaling

Crohn's disease - possible genetic cause found

Do guidelines for the treatment of osteoporosis in patients with inflammatory bowel disease (IBD) matter?

Importance of T cells in the prevention of autoimmune diseases

Major intestinal surgery may boost the chances of subsequent vitamin A deficiency

Microbes could represent the future of medicine

Humans are a cocktail of bacteria and human cells

Gene variation linked to more severe Crohn's disease

Study reveals how production of interferon gamma is controlled in natural killer cells

Stem cell 'fusion' occurs in tumors

IL-25 both promotes and limits inflammatory diseases

MIT look at how cells make life-or-death decisions

Data from Novogen inflammatory bowel disease drug Phase I clinical trial shows promise

Drugs formerly contraindicated for inflammatory bowel disease prove beneficial for pain relief

CT enteroclysis should replace conventional enteroclysis in patients with Crohn's disease

Eosinophilic esophagitis gene discovery

New biochip predicts evolution of inflammatory bowel disease

UCLA examines disease-versus-disease interactions

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Inflammatory Bowel Disease News and Research

Latest Inflammatory Bowel Disease News and Research

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in